References
- Wedzicha JA, Calverley PM, Rabe KF. Roflumilast: a review of its use in the treatment of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1–3. doi: 10.2147/COPD.S89849.
- Milakovic M, Gooderham MJ. Phosphodiesterase-4 inhibition in psoriasis. Psoriasis. 2021;11:21–29. doi: 10.2147/ptt.s303634.
- Maiga MC, Ahidjo BA, Maiga M, et al. Roflumilast, a type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis. Antimicrob Agents Chemother. 2015;59(12):7888–7890. doi: 10.1128/AAC.02145-15.
- Ring HC, Egeberg A, Zachariae C, et al. Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy. Br J Dermatol. 2022;187(5):813–815. doi: 10.1111/bjd.21744.
- Gyldenløve M, Meteran H, Zachariae C, et al. Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapy. Br J Dermatol. 2022;187(2):258–259. doi: 10.1111/bjd.21044.
- Gyldenløve M, Meteran H, Zachariae C, et al. Long-term clearance of severe plaque psoriasis with oral roflumilast. J Eur Acad Dermatol Venereol. 2023;37(3):e429–e430. doi: 10.1111/jdv.18647.
- Egeberg A, Meteran H, Gyldenløve M, et al. Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy. Br J Dermatol. 2021;185(6):1251–1252. doi: 10.1111/bjd.20602.
- Gyldenløve M, Egeberg A. Killing all the birds with one drug–is oral roflumilast a novel treatment option for psoriasis? J Dermatolog Treat. 2022;33(6):2782–2783. doi: 10.1080/09546634.2022.2069223.
- Michels K, Hagner M, El Zein M, et al. Treating 2 diseases with 1 drug: PDE-4 inhibitor for COPD and psoriasis. Am J Ther. 2017;24(1):e103–e104. doi: 10.1097/MJT.0000000000000465.
- Gyldenløve M, Meteran H, Sørensen JA, et al. Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO). Lancet Reg Health Eur. 2023;30:100639. doi: 10.1016/j.lanepe.2023.100639.
- Pixley JN, Schaetzle T, Feldman SR. A review of topical roflumilast for the treatment of plaque psoriasis. Ann Pharmacother. 2023;57(8):966–969. doi: 10.1177/10600280221137750.